Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000255

Drug Information
IndicationIleus, Gastroparesis, Miscellaneous Gastrointestinal DisordersPhase IIb    [1]
TargetGrowth hormone secretagogue receptor type 1Agonist[2][3][4]
Ref 1Emerging drugs for postoperative ileus. Expert Opin Emerg Drugs. 2007 Nov;12(4):619-26. To Reference
Ref 2Contribution of protein binding to the pharmacokinetics of the ghrelin receptor agonist TZP-101 in healthy volunteers and adults with symptomatic gastroparesis: two randomized, double-blind studies and a binding profile study. Clin Drug Investig. 2009;29(6):409-18. doi: 10.2165/00044011-200929060-00004. To Reference
Ref 3Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther. 2009 Jun 1;29(11):1179-87. Epub 2009 Feb 27. To Reference
Ref 4Eur J Pharmacol. 2009 Feb 14;604(1-3):132-7. Epub 2008 Dec 14.Effect of the ghrelin receptor agonist TZP-101 on colonic transit in a rat model of postoperative ileus. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543